Hoechst Aktiengesellschaft

Sugata Chatterjee

Bimal N Ganguli

Hans-Wolfram Fehlhaber

Herbert Kogler

Erra K Vijayakumar

Jurgen Blumbach

Christopher M Franco

Richard H Rupp

Suresh R Nadkarni

Kalvanapuram R Desikan

Mahesh V Patel

Volker Teetz

Gerhard Seibert

Goukanapalli C Reddy

Julia Gandhi

Deepak K Chatterjee

Rajendra K Jani

Sukumar Chatterjee

Balhimycin, a compound of the molecular formula C.sub.66 H.sub.73 C1.sub.2 N.sub.9 0.sub.24, is a novel Glycopeptide antibiotic and has the following structure: ##STR1##

Antibiotic, balhimycin, a process for its production and its use as

Balhimycin, a compound of the molecular formula C.sub.66 H.sub.73 Cl.sub.2 N.sub.9 O.sub.24, is a novel Glycopeptide antibiotic and has the following structure (SEQ. ID. No. 1): ##STR1##

Cammunocin, an active substance which can be obtained by cultivation of Streptomyces species Y-84,36210 (DSM 4329), has antibiotic and immunosuppressant activity.

Antibiotic, cammunocin, a process for the preparation thereof, and the

Butalactin, a compound of the formula I ##STR1## can be produced by cultivation of Streptomyces species Y-86,36923. Butalactin has an antibiotic activity.

Butalactin and its use as pharmaceutical

Alisamycin, a compound of the formula I ##STR1## has an antibiotic, antitumor and antiparasitic action.

Antibiotic alisamycin and its use

Mersacidin, a cyclic peptide of the formula I ##STR1## has antibiotic activity.

Antibiotic, mersacidin, a process for the preparation thereof and the

The present invention relates to the macrolide antibiotic swalpamycin, to a microbiological process for its preparation, to a new microorganism strain Streptomyces species, and to the use of swalpamycin as a medicinal agent for the treatment of infections caused by bacteria, mycoplasmas and Actinomycetes.

Growing community of inventors

Bombay, India

Sugata Chatterjee